Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-03

Clinical Trial Update: Angiotensin-(1-7) in Peripheral Arterial Disease [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Angiotensin-(1-7) for peripheral arterial disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Angiotensin-(1-7) (Angiotensin-(1-7))

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Peripheral Arterial Disease | EARLY_Phase 1 | Status: TERMINATED